iAnthus Expands To The Northeast

iAnthus wil be opening its first Northeast Be. retail store located on Staten Island, planned for March

iAnthus Capital Holdings, Inc, which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, is pleased to announce the opening of its first Northeast Be.retail store located on Staten Island.  A soft opening is planned for March 11, 2020.

The 3,850 square foot store, located at 338 New Dorp Lane, will be the only Registered Organization serving the borough of Staten Island's population of close to 500,000.  A grand opening celebration for Be. Staten Island is scheduled for March 26, 2020.  

"We are thrilled to debut our new Be. retail brand for the patients of Staten Island, who have long been underserved by the legal cannabis market"

Hadley Ford, CEO of iAnthus.

"Bringing safe, tested, quality cannabis and excellent customer service to the medical cannabis patients in New York is our top priority and we look forward to serving the great people of Staten Island with Be. our new, exciting retail concept."

The Company currently operates two medical dispensaries in the state under the Citiva brand, one in Brooklyn and one in Wappingers Falls.  The Wappingers Falls location will be rebranded as Be.shortly after the Staten Island opening.

The flagship Be. store, located in Brooklyn across from the Barclays Center, is expected to open next month. The Company's fourth New York store will be located in Ithaca. 

The Company will be rebranding its existing store base across its operating footprint throughout the remainder of the year.

To learn more about iAnthus Capital visit their Company HQ here

Disclaimer: Past performance is not an indicator of future performance.


This could be one of the best investing opportunities of 2020

Legislative changes are blowing through the US, and with it, an ever-increasing number of states legalising cannabis for recreational use.

With the success seen in Illinois, which legalised for adult-use on January 1 and saw products moving off the shelf at an unprecedented rate, this company is primed to take advantage of the booming US recreational market.

They have secured partnerships with the biggest cannabis companies in the US, and their portfolio is second to none.

And with the sector-wide pullback of 2019, this company is now at a bargain-basement price.

Subscribe Now
& Keep Up to Date

Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!

Niki Mohazeb
Niki Mohazeb

Niki is a Sydney based writer, with a passion for promoting the health benefits of medicinal cannabis. Niki also enjoys researching and writing about the future of cannabis along with the many other benefits that the plant provides, such as the diverse utilities of hemp.

Leave a Reply

Your email address will not be published. Required fields are marked *